Literature DB >> 19758178

Immmunopathogenesis of rheumatoid arthritis; induction of arthritogenic autoimmune responses by proinflammatory stimuli.

Markus Hoffmann1, Silvia Hayer, Guenter Steiner.   

Abstract

Rheumatoid arthritis (RA) is a severe autoimmune disorder of unknown etiology. Major autoantigens include immunoglobulin G (which is targeted by rheumatoid factor), citrullinated proteins, and the heterogeneous nuclear ribonucleoprotein (hnRNP) A2. To obtain more insight into the pathogenic role of arthritogenic autoantigens, we studied autoimmune responses in two animal models of RA, which are independent of immunization with exogenous antigens, namely human tumor necrosis factor-alpha (TNF-alpha)-transgenic (hTNFtg) mice and rats with pristane-induced arthritis (PIA). Serologic and cellular studies revealed autoantibodies to hnRNP-A2 in these animals and pronounced T-cell reactivity to hnRNP-A2 and the presence of rheumatoid factor in PIA, while citrullinated antigens were not targeted. Furthermore, hnRNP-A2 was found to be highly overexpressed in the joints of mice and rats affected by arthritis. Thus, unspecific proinflammatory stimuli, such as TNF-alpha or pristane, may induce pathogenic autoimmune reactions that may drive an inflammatory process, leading to the development of erosive arthritis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19758178     DOI: 10.1111/j.1749-6632.2009.04753.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

1.  Peptidylarginine deiminase 4 contributes to tumor necrosis factor α-induced inflammatory arthritis.

Authors:  Miriam A Shelef; Jeremy Sokolove; Lauren J Lahey; Catriona A Wagner; Eric K Sackmann; Thomas F Warner; Yanming Wang; David J Beebe; William H Robinson; Anna Huttenlocher
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

2.  Lapatinib ameliorates experimental arthritis in rats.

Authors:  Metin Ozgen; Suleyman Serdar Koca; Ahmet Karatas; Adile Ferda Dagli; Fazilet Erman; Baris Gundogdu; Kazim Sahin; Ahmet Isik
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.